Diagnosis and Classification of Pulmonary Hypertension in 2023
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott Vascular; Edwards Lifesciences; Medtronic; Merck; Alleviant; CareDx; Cytokinetics; Itamar; Eidos; Lexicon; Gradient
- travel reimbursement - Abiomed
- Equity/Stock(s)/Options - Aria CV